Bora Pharmaceuticals Competitors and Similar CompaniesClear all

Bora Pharmaceuticals's competitors and similar companies include Tanvex BioPharma, EMS Pharma, Alembic Pharmaceuticals and Cipla.

	Bora Pharmaceuticals Bora Pharmaceuticals is a company that develops, manufactures, and sells branded, generic, and over the counter (OTC) healthcare products.	Tanvex BioPharma Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.	EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date	Founding Date 2007	Founding Date 2013	Founding Date 1964	Founding Date 2010	Founding Date 1935
Type	Type Private	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development outsourcing pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations TW HQ Wilmington, US	Locations Taipei, TW HQ New Taipei, TW Irvine, US San Diego, US San Diego, US	Locations BR HQ	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more
Employees	Employees 6553% increase	Employees 13827% decrease	Employees 12,7441% increase	Employees 14,858	Employees 27,764
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) NT$401m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₹73.4b (FY, 2026)	Revenue (est.) ₹277.1b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods NT$466.3m (FY, 2025)	Cost of goods N/A	Cost of goods ₹19.8b (FY, 2026)	Cost of goods ₹95.5b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit (NT$10.6m) (FY, 2025)	Gross profit N/A	Gross profit ₹54.1b (FY, 2026)	Gross profit ₹195b (FY, 2026)
Net income	Net income N/A	Net income (NT$1.5b) (FY, 2025)	Net income N/A	Net income ₹6.7b (FY, 2026)	Net income ₹38.7b (FY, 2026)
Operating ⚠
Products	Products N/A	Products N/A	Products N/A	Products 145 (FY, 2024)	Products 1.5 k (FY, 2024)